How to treat Lung cancer?

Fuula kana dhaggeeffadhu

Kaansarii sombaa akkamitti wal'aanuu danda'a?

Daa'imni kaansarii sombaa, sadarkaa kaansarii, gosa kaansarii sombaa fi fayyaa waliigalaa dhukkubsataa dabalatee wantoota baay'ee irratti hundaa'a.

Filannoowwan wal'aansoo baramaa ta'an tokko tokko kan akka:

1. Yaaliin baqaqsanii wal'aanuu: Yeroo baay'ee yaaliin baqaqsanii wal'aanuu dhukkuba kaansarii sombaa sadarkaa jalqabaa ta'etti filatamaadha.

Ogeessi baqaqsanii hodhuu kun, dhukkuba kana fi qaama fayyaa naannoo isaa jiru muraasa ni fageessa.

2. Yaaliin raadiyeeshinii: Raadiyeeshiniin humna guddaa qabu seelota kaansarii ajjeesuufis ta'e kaansarii xiqqeessuuf itti fayyadama.

Walumaagalatti ykn walta'iinsa wal'aansa biroo wajjin ta'uun fayyadamuu ni danda'a.

3. Keemootaappiraa: Yaaliin kun qoricha seelota kaansarii ajjeesuuf gargaaru fayyadamu.

Intarvaayinii ykn afaaniin kennamuu kan danda'u yoo ta'u, yeroo baay'ee wal'aansa biroo wajjin walqabatee itti fayyadama.

4. Yaaliin wal'aansa kallattii qabu: Yaaliin wal'aansa kanaa jiinii ykn pirootinii adda ta'e kan guddinaa fi lubbuudhaan jiraachuu seelota kaansariitiif gumaacha godhu irratti kan xiyyeeffate dha.

Yeroo baay'ee kaansarii sombaa sadarkaa ol'aanaa ykn metastaasii ta'e irratti ni fayyadama.

5. Immunotherapy: Yaaliin kun, qaamni dhukkuba ittisuu seelii kaansarii akka hubatufi akka haleelu isa gargaara.

Yeroo baay'ee kaansarii sombaa sadarkaa ol'aanaa ykn metastaasii ta'e irratti ni fayyadama.

6. Yaaliin wal'aansa suuraa (photodynamic therapy): Yaaliin kun seelii kaansarii ajjeesuuf qoricha ifaa (light-activated drug) fayyadamu.

Yeroo baay'ee kaansarii sombaa sadarkaa jalqabaa irratti itti fayyadama.

7. Prooton therapy: Kun gosa radiation therapy kan ta'e yoo ta'u, radiation'n x-ray'n utuu hin ta'in protons'n tumoraatti ergama.

Yeroo baay'ee kaansarii sombaa sadarkaa jalqabaa irratti itti fayyadama.

Qorannoowwan kilinikaa: Dhukkubsattoonni qorannoowwan kilinikaa yaaliiwwan haaraa ykn walta'iinsa yaaliiwwan haaraa qoratan irratti hirmaachuuf mirga qabaachuu danda'u.

Karoorri wal'aansoo bu'a qabeessa ta'e haala dhuunfaa irratti kan hundaa'e waan ta'eef, filannoowwan wal'aansoo gaarii ta'an garee fayyaa waliin mari'achuun barbaachisaadha.

Ilaalchawwan

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Chen JH, Wu J, Xu Q: The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther. , 4 (): 61.

Furuse K: [Photodynamic therapy of centrally located early-stage lung cancer]. Gan To Kagaku Ryoho. 1996, 23 (1): 27-30.

Gálffy G: [From rare mutations to classical ones, inhibition of signaling pathways in non-small cell lung cancer]. Magy Onkol. 2020, 64 (3): 196-204.

Magalhães M, Alvarez-Lorenzo C, Concheiro A, Figueiras A, Santos AC, Veiga F: RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opin Drug Deliv. 2018, 15 (10): 965-982.

Kataoka M, Fujiwara T, Tanaka N: [Gene therapy for lung cancer]. Nihon Geka Gakkai Zasshi. 2002, 103 (2): 244-9.

Jin C, Yang B: A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient. Case Rep Oncol. , 14 (1): 659-663.

Wang Y, Liu Q, Chen H, You J, Peng B, Cao F, Zhang X, Chen Q, Uzan G, Xu L, Zhang D: Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance. Anticancer Drugs. 2018, 29 (8): 748-755.

Ejjennoo: fayyaa

Weebsaayitiin kun kaayyoo barnootaa fi odeeffannoo qofaaf kan qophaa'e yoo ta'u, gorsa fayyaa ykn tajaajila ogummaa kennuu miti.

Odeeffannoon kenname kun rakkoo fayyaa ykn dhukkuba tokko adda baasuuf ykn wal'aanuuf itti fayyadamuu hin qabu, namoonni gorsa fayyaa dhuunfaa barbaadanis ogeessa fayyaa hayyama qabu wajjin mari'achuu qabu.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numerical content. For example, the number of people diagnosed with a specific disease.

Yeroo hunda waa'ee dhukkuba tokkoo gorsa ogeessa fayyaa ykn ogeessa fayyaa ga'eessa ta'e biraa gaafadhu. Gorsa fayyaa ogeessaa hin tuffatin ykn waan weebsaayitii kana irratti dubbisteef isa barbaaduu hin daangeffatin. Yoo rakkoo fayyaa qabaachuu dandeessan yoo ta'e, hatattamaan 911 bilbilaa ykn gara kutaa ariifachiisaa dhihoo deemaa. Weebsaayitii kana ykn itti fayyadama isaatiin hariiroon ogeessa fayyaa fi dhukkubsataa hin uumamu. BioMedLib ykn hojjettoonni isaa, ykn namni weebsaayitii kana irratti gumaache kamiyyuu, odeeffannoo asitti kenname ykn itti fayyadama isaa ilaalchisee ibsa ykn yaada hin kennine hin kennine.

Ejjennoo: Mirga bu'uuraa

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) abbootii seeraa meeshaaleen intarneetii irratti mul'atan mirga isaanii seera abbaa seerummaa Yunaayitid Isteetis jalatti cabsu jedhanii amanuuf furmaata ni kenna.

Qabiyyeen ykn meeshaan Weebsaayitii keenya ykn tajaajila keenya waliin walqabatee qophaa'e kamiyyuu mirga abbaa seerummaa keessan kan cabsu akka ta'e amanuu yoo barbaadde, ati (yommuu ta'u bakka bu'aa keessan) qabiyyeen ykn meeshaan kun akka kaafamu ykn akka dhorkamu nutti himachuu ni danda'a.

Beeksisni barreeffamaan ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa ergaa

DMCA'n beeksiinsi keessan waa'ee cabsaa seeraa kan himatamu odeeffannoo armaan gadii akka dabalatu gaafata: (1) ibsa hojii seeraa kan cabsaa seeraa kan himatamu ta'e; (2) ibsa qabiyyee cabsaa seeraa kan himatamu fi odeeffannoo qabiyyee isaa akka argannu nu dandeessisu ga'aa ta'e; (3) odeeffannoo wal qunnamtii keessan, kan akka teessoo keessan, lakkoofsa bilbilaa fi teessoo iimeelii keessan; (4) ibsi keessan qabiyyee akkaataa komatamanitti akka hin hayyamamne amantaa gaarii akka qabdan ibsa;

(5) beeksifannaa keessatti odeeffannoon sirrii akka ta'e fi mirgi abbaa qabeenyaa akka cabse kan himatamu akka ta'e labsii ati mallatteessite;

fi (6) mallattoo qaamaa ykn elektirooniksii abbaa seeraa ykn nama bakka bu'aa abbaa seeraa ta'uun akka hojjetu hayyamame.

Odeeffannoowwan armaan olitti tarreeffaman hunda kan hin dabalne yoo ta'e, dhimmi komii keessan akka hin mari'atamne gochuu danda'a.

Walitti dhufeenyi

Gaaffii / yaada kamirrayyuu qabdan nutti ergi.

How to treat lung cancer?

The treatment for lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the patient's overall health.

Some common treatment options include:

1. Surgery: This is often the preferred treatment for early-stage lung cancer.

The surgeon removes the tumor and a small portion of healthy tissue around it.

2. Radiation therapy: High-energy radiation is used to kill cancer cells and shrink tumors.

It can be used alone or in combination with other treatments.

3. Chemotherapy: This treatment uses drugs to kill cancer cells.

It can be given intravenously or or orally, and is often used in combination with other treatments.

4. Targeted therapy: This treatment targets specific genes or proteins that contribute to the growth and survival of cancer cells.

It is often used for advanced or metastatic lung cancer.

5. Immunotherapy: This treatment helps the immune system recognize and attack cancer cells.

It is often used for advanced or metastatic lung cancer.

6. Photodynamic therapy: This treatment uses a light-activated drug to kill cancer cells.

It is often used for early-stage lung cancer.

7. Proton therapy: This is a type of radiation therapy that uses protons instead of x-rays to deliver radiation to the tumor.

It is often used for early-stage lung cancer.

8. Clinical trials: Patients may be eligible to participate in clinical trials testing new treatments or combinations of treatments.

It is important to discuss the best treatment options with a healthcare team, as the most effective treatment plan will depend on the individual's specific situation.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.